These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25709892)

  • 21. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
    Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
    Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
    Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
    Front Immunol; 2018; 9():977. PubMed ID: 29780393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex chromosomal abnormalities in a patient with refractory anemia with excess blasts (RAEB).
    Christodoulidou F; Coleman M; Macera MJ; Verma RS
    Cancer Genet Cytogenet; 1991 Jul; 54(2):229-32. PubMed ID: 1884355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of the poliovirus receptor expression in malignant lymphocytes by epigenetic alterations.
    Wang W; Gao L; Wang X; Kang H; Li Y; Wang L; Yu L
    J Immunother; 2011 May; 34(4):353-61. PubMed ID: 21499126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome.
    Sohlberg E; Pfefferle A; Andersson S; Baumann BC; Hellström-Lindberg E; Malmberg KJ
    Oncotarget; 2015 Oct; 6(33):34178-90. PubMed ID: 26497557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies.
    Gang AO; Frøsig TM; Brimnes MK; Lyngaa R; Treppendahl MB; Grønbæk K; Dufva IH; Straten PT; Hadrup SR
    Blood Cancer J; 2014 Mar; 4(3):e197. PubMed ID: 24681961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
    Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.
    Khaznadar Z; Henry G; Setterblad N; Agaugue S; Raffoux E; Boissel N; Dombret H; Toubert A; Dulphy N
    Eur J Immunol; 2014 Oct; 44(10):3068-80. PubMed ID: 25041786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
    Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell acute lymphoblastic leukemia with natural killer cell phenotype.
    Kaplan J; Ravindranath Y; Inoue S
    Am J Hematol; 1986 Aug; 22(4):355-64. PubMed ID: 3487974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy.
    Mastaglio S; Wong E; Perera T; Ripley J; Blombery P; Smyth MJ; Koldej R; Ritchie D
    Blood Adv; 2018 Feb; 2(4):335-346. PubMed ID: 29449224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
    Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
    Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9.
    Chau D; Ng K; Chan TS; Cheng YY; Fong B; Tam S; Kwong YL; Tse E
    J Hematol Oncol; 2015 May; 8():46. PubMed ID: 25953102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
    Romee R; Rosario M; Berrien-Elliott MM; Wagner JA; Jewell BA; Schappe T; Leong JW; Abdel-Latif S; Schneider SE; Willey S; Neal CC; Yu L; Oh ST; Lee YS; Mulder A; Claas F; Cooper MA; Fehniger TA
    Sci Transl Med; 2016 Sep; 8(357):357ra123. PubMed ID: 27655849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma soluble interleukin 2 receptor level correlates with defective natural killer and CD8+ T-cells in myelodysplastic syndromes.
    Yokose N; Ogata K; Ito T; An E; Tamura H; Dan K; Hamaguchi H; Sakamaki H; Onozawa Y; Nomura T
    Leuk Res; 1994 Oct; 18(10):777-82. PubMed ID: 7934136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.